NRT SMOKING CESSATION AIDS IN THE NETHERLANDS

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Demand Is Buoyed by the Tougher Regulatory Environment for Tobacco Products

Dutch Smokers Are Likely To Continue To Try and Quit Smoking

Reimbursement of Prescription Rivals Negatively Affects OTC Demand

Competitive Landscape

Nrt Smoking Cessation Aids Remains Highly Consolidated

Drugstore Private Label Lines Are the Only Serious Competition To Major Brands

Consolidation Holds Back Product Innovation

Category Indicators

Table 1 Number of Smokers by Gender 2013-2018

Category Data

Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2013-2018

Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2013-2018

Table 4 Sales of NRT Gum by Flavour: % Value 2013-2018

Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2014-2018

Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2015-2018

Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023

Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023

Executive Summary

Moderate Value Growth, Largely Driven by Non-otc Categories

OTC Sales Are Not (yet) Lifted by the Brighter Macroeconomy

Pharmaceutical Multinationals Dominate, With Private Label the Main Rival

Supermarkets Gains Ground, To the Detriment of Chemists/pharmacies

Modest Value Growth Over the Forecast Period

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Summary 1 OTC: Switches

Market Indicators

Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 10 Life Expectancy at Birth 2013-2018

Market Data

Table 11 Sales of Consumer Health by Category: Value 2013-2018

Table 12 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 13 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 14 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2013-2018

Table 16 Distribution of Consumer Health by Format: % Value 2013-2018

Table 17 Distribution of Consumer Health by Format and Category: % Value 2018

Table 18 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Sources

Summary 2 Research Sources

NRT smoking cessation aids maintained its encouraging performance of recent years in 2018, registering growth above the overall OTC average. The main factor driving demand was the increasingly difficult regulatory environment confronting tobacco manufacturers. As smoking becomes more marginalised and societal disapproval becomes more pronounced, a larger share of active smokers will attempt to quit smoking.

Euromonitor International's NRT Smoking Cessation Aids in Netherlands report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.